This protocol is judged by an institutional critique board, an unbiased group that assessments any medical trials involving humans. If a study entails a Schedule I drug, when the board approves the protocol as ethical, the scientists really need to apply for an investigational new drug (IND) range in the FDA.In spite of its layers of security and v… Read More